Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Apr 1;177(4):937–947. doi: 10.1084/jem.177.4.937

A requirement for membrane-associated phospholipase A2 in platelet cytotoxicity activated by receptors for immunoglobulin G and complement

PMCID: PMC2190973  PMID: 8459221

Abstract

Platelets are potent antibody- and complement-dependent cytotoxic effector cells. We showed previously that a single platelet can lyse a target cell sensitized with immunoglobulin G (IgG) and complement components up to C3 (C integral of 3b denotes the target cell-bound fragment of complement up to C3; the precise nature of the bound C3 fragment has not been established), and that the complete cytotoxic system capable of specific recognition and lysis resides in platelet membranes. To define the components of platelet membranes required for cytotoxicity, a set of inhibitors of phospholipase A2 (PLA2) that act by different chemical mechanisms was tested. The lytic reaction is blocked at appropriate concentrations of bromophenacylbromide, mepacrine, and manoalide. When platelets are treated with bromophenacylbromide, inhibition of cytolytic activity and that of PLA2 enzymatic activity occur in parallel. Platelets release arachidonate when incubated with target cells bearing IgG and C integral of 3b, confirming that Fc gamma R and complement receptor trigger both PLA2 action and efficient lysis. Inhibition by thimerosal of a reverse reaction, i.e., reacylation catalyzed by acyltransferase, causes increased target cell lysis, presumably by increasing the products of PLA2 action. Platelet cytotoxicity is increased when platelets are pretreated with some products of PLA2: exogenous lysophospholipids and not free arachidonic acid increase cytotoxicity. Electron microscopy suggests that platelets and target cells may fuse, possibly as a result of the formation of lysophospholipids which are well-known membrane fusogens. Fixation with paraformaldehyde does not affect platelet cytotoxicity, suggesting that the complete cytotoxic system resides as a preformed complex in platelet membranes. The results indicate that platelet membrane-associated PLA2, together with receptors for Fc and complement, are required for platelet cytotoxicity.

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G. P., Anderson C. L. Signal transduction by the platelet Fc receptor. Blood. 1990 Sep 15;76(6):1165–1172. [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Bennett C. F., Mong S., Wu H. L., Clark M. A., Wheeler L., Crooke S. T. Inhibition of phosphoinositide-specific phospholipase C by manoalide. Mol Pharmacol. 1987 Nov;32(5):587–593. [PubMed] [Google Scholar]
  4. Best L., Sener A., Mathias P. C., Malaisse W. J. Inhibition by mepacrine and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets. Biochem Pharmacol. 1984 Aug 15;33(16):2657–2662. doi: 10.1016/0006-2952(84)90641-5. [DOI] [PubMed] [Google Scholar]
  5. Chang J., Musser J. H., McGregor H. Phospholipase A2: function and pharmacological regulation. Biochem Pharmacol. 1987 Aug 1;36(15):2429–2436. doi: 10.1016/0006-2952(87)90512-0. [DOI] [PubMed] [Google Scholar]
  6. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  7. Costa J. L., Murphy D. L. Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature. 1975 May 29;255(5507):407–408. doi: 10.1038/255407a0. [DOI] [PubMed] [Google Scholar]
  8. Deem R. L., Britvan L. J., Targan S. R. Definition of a secondary target cell trigger during natural killer cell cytotoxicity: possible role of phospholipase A2. Cell Immunol. 1987 Dec;110(2):253–264. doi: 10.1016/0008-8749(87)90121-3. [DOI] [PubMed] [Google Scholar]
  9. Glaser K. B., de Carvalho M. S., Jacobs R. S., Kernan M. R., Faulkner D. J. Manoalide: structure-activity studies and definition of the pharmacophore for phospholipase A2 inactivation. Mol Pharmacol. 1989 Nov;36(5):782–788. [PubMed] [Google Scholar]
  10. Golan D. E., Brown C. S., Cianci C. M., Furlong S. T., Caulfield J. P. Schistosomula of Schistosoma mansoni use lysophosphatidylcholine to lyse adherent human red blood cells and immobilize red cell membrane components. J Cell Biol. 1986 Sep;103(3):819–828. doi: 10.1083/jcb.103.3.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goppelt-Struebe M., Koerner C. F., Hausmann G., Gemsa D., Resch K. Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins. 1986 Sep;32(3):373–385. doi: 10.1016/0090-6980(86)90006-7. [DOI] [PubMed] [Google Scholar]
  12. Hannigan G. E., Williams B. R. Signal transduction by interferon-alpha through arachidonic acid metabolism. Science. 1991 Jan 11;251(4990):204–207. doi: 10.1126/science.1898993. [DOI] [PubMed] [Google Scholar]
  13. Hibbs M. L., Classon B. J., Walker I. D., McKenzie I. F., Hogarth P. M. The structure of the murine Fc receptor for IgG. Assignment of intrachain disulfide bonds, identification of N-linked glycosylation sites, and evidence for a fourth form of Fc receptor. J Immunol. 1988 Jan 15;140(2):544–550. [PubMed] [Google Scholar]
  14. Hoffman T., Hirata F., Bougnoux P., Fraser B. A., Goldfarb R. H., Herberman R. B., Axelrod J. Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3839–3843. doi: 10.1073/pnas.78.6.3839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hofmann S. L., Prescott S. M., Majerus P. W. The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. Arch Biochem Biophys. 1982 Apr 15;215(1):237–244. doi: 10.1016/0003-9861(82)90300-9. [DOI] [PubMed] [Google Scholar]
  16. Ibele G. M., Kay N. E., Johnson G. J., Jacob H. S. Human platelets exert cytotoxic effects on tumor cells. Blood. 1985 May;65(5):1252–1255. [PubMed] [Google Scholar]
  17. Jain M. K., Jahagirdar D. V. Action of phospholipase A2 on bilayers. Effect of inhibitors. Biochim Biophys Acta. 1985 Apr 11;814(2):319–326. doi: 10.1016/0005-2736(85)90451-1. [DOI] [PubMed] [Google Scholar]
  18. Johnson R. J., Pasternack G. R., Shin H. S. Antibody-mediated suppression of tumor growth. II. Macrophage and platelet cooperation with murine IgG1 isolated from alloantiserum. J Immunol. 1977 Feb;118(2):494–497. [PubMed] [Google Scholar]
  19. Joseph M., Auriault C., Capron A., Vorng H., Viens P. A new function for platelets: IgE-dependent killing of schistosomes. Nature. 1983 Jun 30;303(5920):810–812. doi: 10.1038/303810a0. [DOI] [PubMed] [Google Scholar]
  20. King M., McDermott P., Schreiber A. D. Characterization of the Fc gamma receptor on human platelets. Cell Immunol. 1990 Jul;128(2):462–479. doi: 10.1016/0008-8749(90)90041-o. [DOI] [PubMed] [Google Scholar]
  21. Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative. J Immunol. 1988 May 1;140(9):3066–3072. [PubMed] [Google Scholar]
  22. Kramer R. M., Checani G. C., Deykin A., Pritzker C. R., Deykin D. Solubilization and properties of Ca2+-dependent human platelet phospholipase A2. Biochim Biophys Acta. 1986 Oct 3;878(3):394–403. doi: 10.1016/0005-2760(86)90248-1. [DOI] [PubMed] [Google Scholar]
  23. Lennartz M. R., Brown E. J. Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human monocytes. J Immunol. 1991 Jul 15;147(2):621–626. [PubMed] [Google Scholar]
  24. Lister M. D., Glaser K. B., Ulevitch R. J., Dennis E. A. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. J Biol Chem. 1989 May 25;264(15):8520–8528. [PubMed] [Google Scholar]
  25. Martin F. J., MacDonald R. C. Lipid vesicle-cell interactions. II. Induction of cell fusion. J Cell Biol. 1976 Sep;70(3):506–514. doi: 10.1083/jcb.70.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. McCaffery P. J., Tan A. S., Berridge M. V. Polymorphic glycoprotein-1 on mouse platelets: possible role of Pgp-1 and LFA-1 in antibody-dependent platelet cytotoxicity involving complement. Blood. 1987 Jan;69(1):211–218. [PubMed] [Google Scholar]
  27. Murakami M., Kudo I., Fujimori Y., Suga H., Inoue K. Group II phospholipase A2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells. Biochem Biophys Res Commun. 1991 Dec 16;181(2):714–721. doi: 10.1016/0006-291x(91)91249-c. [DOI] [PubMed] [Google Scholar]
  28. Narasimhan V., Holowka D., Baird B. A guanine nucleotide-binding protein participates in IgE receptor-mediated activation of endogenous and reconstituted phospholipase A2 in a permeabilized cell system. J Biol Chem. 1990 Jan 25;265(3):1459–1464. [PubMed] [Google Scholar]
  29. Nishijima J., Wright T. M., Hoffman R. D., Liao F., Symer D. E., Shin H. S. Lysophosphatidylcholine metabolism to 1,2-diacylglycerol in lymphoblasts: involvement of a phosphatidylcholine-hydrolyzing phospholipase C. Biochemistry. 1989 Apr 4;28(7):2902–2909. doi: 10.1021/bi00433a023. [DOI] [PubMed] [Google Scholar]
  30. Orloff D. G., Ra C. S., Frank S. J., Klausner R. D., Kinet J. P. Family of disulphide-linked dimers containing the zeta and eta chains of the T-cell receptor and the gamma chain of Fc receptors. Nature. 1990 Sep 13;347(6289):189–191. doi: 10.1038/347189a0. [DOI] [PubMed] [Google Scholar]
  31. Pancré V., Cesbron J. Y., Auriault C., Joseph M., Chandenier J., Capron A. IgE-dependent killing of Brugia malayi microfilariae by human platelets and its modulation by T cell products. Int Arch Allergy Appl Immunol. 1988;85(4):483–486. doi: 10.1159/000234556. [DOI] [PubMed] [Google Scholar]
  32. Purdon A. D., Patelunas D., Smith J. B. Evidence for the release of arachidonic acid through the selective action of phospholipase A2 in thrombin-stimulated human platelets. Biochim Biophys Acta. 1987 Aug 15;920(3):205–214. doi: 10.1016/0005-2760(87)90096-8. [DOI] [PubMed] [Google Scholar]
  33. Ravetch J. V., Luster A. D., Weinshank R., Kochan J., Pavlovec A., Portnoy D. A., Hulmes J., Pan Y. C., Unkeless J. C. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science. 1986 Nov 7;234(4777):718–725. doi: 10.1126/science.2946078. [DOI] [PubMed] [Google Scholar]
  34. Rosenfeld S. I., Looney R. J., Leddy J. P., Phipps D. C., Abraham G. N., Anderson C. L. Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest. 1985 Dec;76(6):2317–2322. doi: 10.1172/JCI112242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Rufini S., Pedersen J. Z., Desideri A., Luly P. Beta-bungarotoxin-mediated liposome fusion: spectroscopic characterization by fluorescence and ESR. Biochemistry. 1990 Oct 16;29(41):9644–9651. doi: 10.1021/bi00493a020. [DOI] [PubMed] [Google Scholar]
  36. Schramm M. Transfer of glucagon receptor from liver membranes to a foreign adenylate cyclase by a membrane fusion procedure. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1174–1178. doi: 10.1073/pnas.76.3.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shin H. S., Hayden M. L., Gately C. L. Antibody-mediated suppression of lymphoma: participation of platelets, lymphocytes, and nonphagocytic macrophages. Proc Natl Acad Sci U S A. 1974 Jan;71(1):163–166. doi: 10.1073/pnas.71.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Shin H. S., Hayden M., Langley S., Kaliss N., Smith M. R. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts. J Immunol. 1975 Apr;114(4):1255–1263. [PubMed] [Google Scholar]
  39. Slezak S., Symer D. E., Shin H. S. Platelet-mediated cytotoxicity. Role of antibody and C3, and localization of the cytotoxic system in membranes. J Exp Med. 1987 Aug 1;166(2):489–505. doi: 10.1084/jem.166.2.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Smith J. B., Dangelmaier C., Mauco G. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes. Biochim Biophys Acta. 1985 Jul 9;835(2):344–351. doi: 10.1016/0005-2760(85)90290-5. [DOI] [PubMed] [Google Scholar]
  41. Soper W. D., Bartlett S. P., Winn H. J. Lysis of antibody-coated cells by platelets. J Exp Med. 1982 Oct 1;156(4):1210–1221. doi: 10.1084/jem.156.4.1210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Suzuki T., Sadasivan R., Saito-Taki T., Stechschulte D. J., Balentine L., Helmkamp G. M., Jr Studies of Fc gamma receptors of human B lymphocytes: phospholipase A2 activity of Fc gamma receptors. Biochemistry. 1980 Dec 23;19(26):6037–6044. doi: 10.1021/bi00567a014. [DOI] [PubMed] [Google Scholar]
  43. Suzuki T., Saito-Taki T., Sadasivan R., Nitta T. Biochemical signal transmitted by Fc gamma receptors: phospholipase A2 activity of Fc gamma 2b receptor of murine macrophage cell line P388D1. Proc Natl Acad Sci U S A. 1982 Jan;79(2):591–595. doi: 10.1073/pnas.79.2.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Tangen O., Berman H. J., Marfey P. Gel filtration. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh. 1971 Jun 30;25(2):268–278. [PubMed] [Google Scholar]
  45. Verheij H. M., Volwerk J. J., Jansen E. H., Puyk W. C., Dijkstra B. W., Drenth J., de Haas G. H. Methylation of histidine-48 in pancreatic phospholipase A2. Role of histidine and calcium ion in the catalytic mechanism. Biochemistry. 1980 Feb 19;19(4):743–750. doi: 10.1021/bi00545a021. [DOI] [PubMed] [Google Scholar]
  46. Vik D. P., Fearon D. T. Cellular distribution of complement receptor type 4 (CR4): expression on human platelets. J Immunol. 1987 Jan 1;138(1):254–258. [PubMed] [Google Scholar]
  47. Waite M. Approaches to the study of mammalian cellular phospholipases. J Lipid Res. 1985 Dec;26(12):1379–1388. [PubMed] [Google Scholar]
  48. Weltzien H. U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta. 1979 Aug 20;559(2-3):259–287. doi: 10.1016/0304-4157(79)90004-2. [DOI] [PubMed] [Google Scholar]
  49. Wheeler L. A., Sachs G., De Vries G., Goodrum D., Woldemussie E., Muallem S. Manoalide, a natural sesterterpenoid that inhibits calcium channels. J Biol Chem. 1987 May 15;262(14):6531–6538. [PubMed] [Google Scholar]
  50. Yong E. C., Chi E. Y., Fritsche T. R., Henderson W. R., Jr Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane. J Exp Med. 1991 Jan 1;173(1):65–78. doi: 10.1084/jem.173.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Young J. D., Unkeless J. C., Kaback H. R., Cohn Z. A. Mouse macrophage Fc receptor for IgG gamma 2b/gamma 1 in artificial and plasma membrane vesicles functions as a ligand-dependent ionophore. Proc Natl Acad Sci U S A. 1983 Mar;80(6):1636–1640. doi: 10.1073/pnas.80.6.1636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ziomek C. A., Schulman S., Edidin M. Redistribution of membrane proteins in isolated mouse intestinal epithelial cells. J Cell Biol. 1980 Sep;86(3):849–857. doi: 10.1083/jcb.86.3.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. van den Bosch H. Phosphoglyceride metabolism. Annu Rev Biochem. 1974;43(0):243–277. doi: 10.1146/annurev.bi.43.070174.001331. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES